Resistin 420C/G gene polymorphism on circulating resistin, metabolic risk factors and insulin resistance in adult women

Immunol Lett. 2014 Dec;162(2 Pt B):287-91. doi: 10.1016/j.imlet.2014.07.009. Epub 2014 Aug 1.

Abstract

Objective: To investigate the frequency association between resistin gene polymorphism with its circulating levels, metabolic risk factor and insulin resistance in adult women.

Design: Totally 615 subjects were enrolled for the study, 305 women were with metabolic syndrome and 310 women were without metabolic syndrome according to NCEP-ATP III criteria. Fasting circulatory level of resistin, insulin, plasma glucose and lipid profiles were estimated along with calculation of insulin resistance. Resistin 420C/G promoter region polymorphism was done by RFLP method.

Results: Variant genotype (CC vs CG+GG) (p<0.001: OR=2.22: 95% CI=1.60-3.10) of 420C/G resistin gene polymorphism was less frequently observed in control population. Further dividing subjects into two groups according to absence (Resistin -1) or presence (Resistin-2) of the G allele, significantly high levels of triglyceride (p<0.001), plasma glucose (p=0.012), systolic blood pressure (p<0.001), diastolic blood pressure (p<0.001), waist hip ratio (p<0.001), body mass index (p<0.001) and resistin (p<0.001), were observed in resistin-2 group.

Conclusion: Present study shows that 420C/G polymorphism of resistin gene directly correlated to its high circulating level and metabolic risk factors, specifically markers of obesity and atherosclerosis, so it may have an important role in the development of metabolic syndrome and cardio metabolic diseases.

Keywords: Insulin resistance; Metabolic syndrome; Resistin level; Resistin promoter gene polymorphism.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alleles*
  • Atherosclerosis / blood
  • Atherosclerosis / genetics
  • Atherosclerosis / immunology
  • Blood Pressure
  • Female
  • Humans
  • Metabolic Syndrome / blood
  • Metabolic Syndrome / genetics*
  • Metabolic Syndrome / immunology
  • Obesity / blood
  • Obesity / genetics
  • Obesity / immunology
  • Polymorphism, Restriction Fragment Length*
  • Promoter Regions, Genetic*
  • Resistin / blood
  • Resistin / genetics*
  • Resistin / immunology
  • Risk Factors
  • Triglycerides / blood
  • Triglycerides / immunology

Substances

  • RETN protein, human
  • Resistin
  • Triglycerides